SCHEMBL7114019

SCHEMBL7114019

CNC(=O)NS(=O)(=O)c1cc(CCNC(=O)/C=C/c2ccc(OC)cc2OC)ccc1OC

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LY96 Q9Y6Y9 1/20 0.60
MAPT P10636 7/20 0.53
LMNA P02545 2/20 0.51
HPGD P15428 1/20 0.51
HTT P42858 1/20 0.51
ALDH1A1 P00352 3/20 0.48
KDM4E B2RXH2 2/20 0.48
PKM P14618 1/20 0.48
ABCC9 O60706 1/20 0.47
ABCC8 Q09428 1/20 0.47
KCNJ11 Q14654 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.46
BCHE P06276 1/20 0.46
ACHE P22303 1/20 0.46
MAPK1 P28482 1/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
OPRM1 P35372 1/20 0.45
OPRD1 P41143 1/20 0.45
ATM Q13315 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7114022 1.00 LY96 (0.60) LY96MAPTLMNAHPGDHTT
SCHEMBL7114290 0.93 LY96 (0.53) LY96MAPTLMNAHPGDHTT
SCHEMBL4259020 0.93 LY96 (0.53) LY96MAPTLMNAHPGDHTT
SCHEMBL7116287 0.92 LY96 (0.59) LY96MAPTLMNAHPGDHTT
SCHEMBL7116284 0.92 LY96 (0.59) LY96MAPTLMNAHPGDHTT
SCHEMBL7113055 0.91 ABCC9 (0.59) LY96MAPTLMNAHPGDHTT
SCHEMBL4256436 0.91 ABCC9 (0.59) LY96MAPTLMNAHPGDHTT
SCHEMBL7114351 0.87 LY96 (0.57) LY96MAPTLMNAHPGDHTT
SCHEMBL7114348 0.87 LY96 (0.57) LY96MAPTLMNAHPGDHTT
SCHEMBL7113245 0.87 MAPT (0.52) LY96MAPTLMNAHPGDHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1183236-B1 CINNAMOYLAMINOALKYL-SUBSTITUTED BENZENESULFONAMIDE DERIVATIVES AVENTIS PHARMA GMBH (DE) 2003-10-22 EP disclosed
EP-1183236-A1 CINNAMOYLAMINOALKYL-SUBSTITUTED BENZENESULFONAMIDE DERIVATIVES Aventis Pharma Deutschland GmbH (DE) 2002-03-06 EP disclosed
US-6350778-B1 CARDIOVASCULAR DISORDERS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2002-02-26 US disclosed
WO-2000071513-A1 CINNAMOYLAMINOALKYL-SUBSTITUTED BENZENESULFONAMIDE DERIVATIVES AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2000-11-30 WO disclosed